THE DEVELOPMENT OF AN ELUTED STAIN BIOASSAY (ESTA) FOR HUMAN GROWTH-HORMONE

被引:0
|
作者
EALEY, PA
YATEMAN, ME
SANDHU, R
DATTANI, MT
HASSAN, MK
HOLT, SJ
MARSHALL, NJ
机构
[1] UCL, SCH MED, DEPT MOLEC PATHOL, LONDON W1N 8AA, ENGLAND
[2] UCL, SCH MED, ENDOCRINE UNIT, LONDON W1N 8AA, ENGLAND
[3] UCL, SCH MED, DEPT BIOCHEM, LONDON W1N 8AA, ENGLAND
[4] ST BARTHOLOMEWS HOSP, DEPT CHEM ENDOCRINOL, LONDON, ENGLAND
来源
GROWTH REGULATION | 1995年 / 5卷 / 01期
关键词
GROWTH HORMONE; BIOASSAY; MTT; ESTA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The basic characteristics of MTT-formazan production by both quiescent Nb2 cells and those activated by fetal calf serum or human growth hormone (hGH) are described. These characteristics are exploited for the development of an MTT-ESTA bioassay for purified preparations of lactogens such as growth hormone. The resulting in vitro bioassay is sensitive and precise, with a detection limit of about 0.05 mU hGH/l (19 ng/l) and a within-assay imprecision of 2.5% in the presence of 0.3 mU hGH/l (114 ng/l). When utilizing quiescent Nb2 cells for bioassays, large magnitudes of response are observed. The major component of the response is clearly derived from metabolic activation of the cells, rather than increased cell proliferation. The response was abolished by anti-human growth hormone. Delayed addition of the latter demonstrated that the presence of the hormone is required for the entire 96 h of the recommended bioassay incubation period to obtain the maximum response. At high doses, the dose-response relationship reaches a prolonged plateau which covers 4 orders of magnitude of incremental hormone concentrations. A decline in response is observed at the highest dose tested, 10(6) mU hGH/l (385 mg/l). This auto-inhibition is consistent with recent reports of a reduction in response due to stoichiometric blockade of sequential receptor dimerisation which is crucial for activation of both somatogenic and lactogenic receptors by hGH.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 50 条
  • [21] THE INTERNATIONAL STANDARD FOR HUMAN GROWTH-HORMONE FOR BIOASSAY - CALIBRATION AND CHARACTERIZATION BY INTERNATIONAL COLLABORATIVE STUDY
    BANGHAM, DR
    DAS, REG
    SCHULSTER, D
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1985, 42 (03) : 269 - 282
  • [22] CHARACTERIZATION OF DIMERIC FORMS OF HUMAN PITUITARY GROWTH-HORMONE BY BIOASSAY, RADIORECEPTOR ASSAY, AND RADIOIMMUNOASSAY
    BROSTEDT, P
    LUTHMAN, M
    WIDE, L
    WERNER, S
    ROOS, P
    ACTA ENDOCRINOLOGICA, 1990, 122 (02): : 241 - 248
  • [23] DOSE DEPENDENCE OF GROWTH RESPONSE TO HUMAN GROWTH-HORMONE IN GROWTH-HORMONE DEFICIENCY
    PREECE, MA
    TANNER, JM
    WHITEHOUSE, RH
    CAMERON, N
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (03): : 477 - 483
  • [24] STAIN FOR DIFFERENTIATING GROWTH-HORMONE AND PROLACTIN PRODUCING CELLS IN ADENOHYPOPHYSIS
    ELETREBY, MF
    TUSHAUS, U
    HISTOCHEMIE, 1973, 33 (02): : 121 - 127
  • [25] HUMAN PITUITARY GROWTH-HORMONE (HGH) THERAPY IN GROWTH-HORMONE DEFICIENCY
    FRASIER, SD
    ENDOCRINE REVIEWS, 1983, 4 (02) : 155 - 170
  • [26] GROWTH-HORMONE AND GROWTH-HORMONE BINDING-PROTEIN IN HUMAN URINE
    HATTORI, N
    SHIMATSU, A
    KATO, Y
    IMURA, H
    KIDNEY INTERNATIONAL, 1990, 37 (03) : 951 - 954
  • [27] TRANSITORY GROWTH-HORMONE DEFICIENCY SUCCESSFULLY TREATED WITH HUMAN GROWTH-HORMONE
    TRYGSTAD, O
    ACTA ENDOCRINOLOGICA, 1977, 84 (01): : 11 - 22
  • [28] RESULTS OF INTERMITTENT TREATMENT OF GROWTH-HORMONE DEFICIENCY WITH HUMAN GROWTH-HORMONE
    PREECE, MA
    TANNER, JM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 45 (01): : 169 - 170
  • [29] GROWTH-HORMONE DEFICIENCY IN DOWN - TREATMENT WITH SYNTHETIC HUMAN GROWTH-HORMONE
    TORRADO, C
    WISNIEWSKI, K
    CASTELLS, S
    PEDIATRIC RESEARCH, 1990, 27 (04) : A87 - A87
  • [30] HUMAN, BOVINE, AND EQUINE GROWTH-HORMONE ANTIBODIES IN PATIENTS TREATED WITH HUMAN GROWTH-HORMONE
    POSKUS, E
    PENA, C
    PEREZ, AR
    VITA, N
    HEINRICH, JJ
    PALADINI, AC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (01): : 13 - 17